Los puntos clave no están disponibles para este artículo en este momento.
. This unique, multipronged approach leads to the characterization of a phenylpyrrolocytosine (PhpC)-based G-clamp analog as a prototype of G4-disrupting small molecule whose properties are validated through many different and complementary in vitro evaluations.
Mitteaux et al. (Wed,) studied this question.